Definition of Barrett's esophagus dysplasia: Are we speaking the same language?

World Journal of Surgery

Volumn 39, Issue 3, 2015, Pages 559-565

  Rugge, Massimo ^a,b   Pizzi, Marco ^a   Castoro, Carlo ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; BARRETT ESOPHAGUS; ESOPHAGUS TUMOR; EUROPE; HUMAN; JAPAN; LOWER ESOPHAGUS SPHINCTER; METAPLASIA; NOMENCLATURE; NORTH AMERICA; PATHOLOGY; PRECANCER;

ADENOCARCINOMA; BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; EUROPE; HUMANS; JAPAN; METAPLASIA; NORTH AMERICA; PRECANCEROUS CONDITIONS; TERMINOLOGY AS TOPIC;

EID: 84928926936     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-014-2692-y     Document Type: Article

References (42)

1. Descartes R (1998) Discourse on method and meditations on first philosophy. Hackett Publishing Company, Indianapolis
2. Barrett NR (1950) Chronic peptic ulcer of the oesophagus and "oesophagitis". Br J Surg 38:175-182
3. Riddell RH, Odze RD (2009) Definition of Barrett's esophagus: time for a rethink - is intestinal metaplasia dead? Am J Gastroenterol 104(10):2588-2594
4. de Jonge PJ, van Blankenstein M, Grady WM et al (2014) Barrett's oesophagus: epidemiology, cancer risk and implications for management. Gut 63(1):191-202
5. Takubo K, Arai T, Sawabe M et al (2003) Structures of the normal esophagus and Barrett's esophagus. Esophagus 1:37-47
6. Hvid-Jensen F, Pedersen L, Drewes AM et al (2011) Incidence of adenocarcinoma among patients with Barrett's esophagus. N Engl J Med 365:1375-1383
7. Rugge M, Capelle LG, Cappellesso R et al (2013) Precancerous lesions in the stomach: from biology to clinical patient management. Best Pract Res Clin Gastroenterol 27(2):205-223
8. Japan Esophageal Society (2009) Japanese classification of esophageal cancer, tenth edition: parts II and III. Esophagus 6:71-94
9. Fitzgerald RC, di Pietro M, Ragunath K et al (2014) British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut 63(1):7-42
10. Jass JR (2000) Discrepancies between East and West. Cancer 88(5):969-970
11. Mueller J, Werner M, Stolte M (2004) Barrett's esophagus: histopathologic definitions and diagnostic criteria. World J Surg 28(2):148-154. doi: 10.1007/s00268-003-7050-4
12. Paull A, Trier JS, Dalton MD et al (1976) The histologic spectrum of Barrett's esophagus. N Engl J Med 295:476-480
13. Fiocca R, Mastracci L, Milione M et al (2011) Microscopic esophagitis and Barrett's esophagus: the histology report. Dig Liver Dis 43(Suppl 4):S319-S330
14. Takubo K, Vieth M, Aida J et al (2009) Differences in the definitions used for esophageal and gastric diseases in different countries: endoscopic definition of the esophagogastric junction, the precursor of Barrett's adenocarcinoma, the definition of Barrett's esophagus, and histologic criteria for mucosal adenocarcinoma or high-grade dysplasia. Digestion 80(4):248-257
15. Sharma P, Dent J, Armstrong D et al (2006) The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. Gastroenterology 131(5):1392-1399
16. Spechler SJ, Sharma P, Souza RF et al (2011) American Gastroenterological Association technical review on the management of Barrett's esophagus. Gastroenterology 140:e18-e52
17. Amano Y, Ishimura N, Furuta K et al (2006) Which landmark results in a more consistent diagnosis of Barrett's esophagus, the gastric folds or the palisade vessels? Gastrointest Endosc 64:206-211
18. Rugge M, Fassan M, Battaglia G et al (2009) Intestinal or gastric? The unsolved dilemma of Barrett's metaplasia. Hum Pathol 40(8):1206-1207
19. Smith RR, Hamilton SR, Boitnott JK et al (1984) The spectrum of carcinoma arising in Barrett's esophagus. A clinicopathologic study of 26 patients. Am J Surg Pathol 8:563-573
20. Bhat S, Coleman HG, Yousef F et al (2011) Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study. J Natl Cancer Inst 103:1049-1057
21. Spechler SJ, Sharma P, Souza RF et al (2011) American Gastroenterological Association medical position statement on the management of Barrett's esophagus. Gastroenterology 140(3):1084-1091
22. Vakil N, van Zanten SV, Kahrilas P et al (2006) The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 101(8):1900-1920
23. Jankowski JA, Harrison RF, Perry I et al (2000) Barrett's metaplasia. Lancet 356(9247):2079-2085
24. Kelty CJ, Gough MD, Van Wyk Q et al (2007) Barrett's oesophagus: intestinal metaplasia is not essential for cancer risk. Scand J Gastroenterol 42(11):1271-1274
25. Takubo K, Aida J, Naomoto Y et al (2009) Cardiac rather than intestinal-type background in endoscopic resection specimens of minute Barrett adenocarcinoma. Hum Pathol 40:65-74
26. Japan Esophageal Society (2009) Japanese classification of esophageal cancer, tenth edition: part I. Esophagus 6:1-25
27. Hahn HP, Blount PL, Ayub K et al (2009) Intestinal differentiation in metaplastic, nongoblet columnar epithelium in the esophagus. Am J Surg Pathol 33(7):1006-1015
28. Fassan M, Volinia S, Palatini J et al (2013) MicroRNA expression profiling in the histological subtypes of Barrett's metaplasia. Clin Transl Gastroenterol 4:e34
29. Oryu M, Mori H, Kobara H et al (2013) Differences in the characteristics of Barrett's esophagus and Barrett's adenocarcinoma between the United States and Japan. ISRN Gastroenterol 2013:840690
30. Odze RD, Riddell RH, Bosman FT et al (2010) Premalignant lesions of the digestive system. In: Bosman FT, Carneiro F, Hruban RH et al (eds) WHO classification of tumours of the digestive system. IARC, Lyon, pp 10-12
31. Schlemper RJ, Itabashi M, Kato Y et al (1997) Differences in diagnostic criteria for gastric carcinoma between Japanese and Western pathologists. Lancet 349(9067):1725-1729
32. Takubo K, Arai T, Ishiguro S (2002) Patient presentation and pathologic diagnosis of superficial carcinoma of the esophagus: high-grade dysplasia and mucosal carcinoma from the Japanese standpoint. In: Imamura M (ed) Superficial esophageal neoplasm: pathology, diagnosis, and therapy. Springer, Tokyo, pp 141-147
33. Rugge M, Correa P, Dixon MF et al (2000) Gastric dysplasia: the Padova international classification. Am J Surg Pathol 24(2):167-176
34. Fassan M, Pizzi M, Farinati F et al (2012) Lesions indefinite for intraepithelial neoplasia and OLGA staging for gastric atrophy. Am J Clin Pathol 137:727-732
35. Japanese Gastric Cancer Association (2011) Japanese classification of esophageal cancer, tenth edition: part I. Gastric Cancer 14:101-112
36. Schlemper RJ, Riddell RH, Kato Y et al (2000) The Vienna classification of gastrointestinal epithelial neoplasia. Gut 47:251-255
37. Dixon MF (2002) Gastrointestinal epithelial neoplasia: Vienna revisited. Gut 51(1):130-131
38. Dobbins W (1966) The intestinal mucosal lymphatic in man. A light and electron microscopic study. Gastroenterol 51(6):994-1003
39. Akashi Y, Noguchi T, Nagai K et al (2011) Cytoarchitecture of the lamina muscularis mucosae and distribution of the lymphatic vessels in the human stomach. Med Mol Morphol 44(1):39-45
40. Flejou JF, Odze RD, Montgomery E et al (2010) Adenocarcinoma of the oesophagus. In: Bosman FT, Carneiro F, Hruban RH et al (eds) WHO classification of tumours of the digestive system. IARC, Lyon, pp 27-28
41. Fassan M, Baffa R, Kiss A et al (2013) MicroRNA dysregulation in esophageal neoplasia: the biological rationale for novel therapeutic options. Curr Pharm Des 19(7):1236-1241
42. Pizzi M, Fassan M, Realdon S et al (2012) Anterior gradient 2 profiling in Barrett columnar epithelia and adenocarcinoma. Hum Pathol 43(11):1839-1844